The 2011 APSAD Conference features an exciting breadth of international and national keynote speakers.
Professor Gabriele Bammer
National Centre for Epidemiology and Population Health The Australian National University
Gabriele Bammer is a professor at the National Centre for Epidemiology and Population Health, ANU College of Medicine, Biology and Environment, The Australian National University. She is also a research fellow at the Program in Criminal Justice Policy and Management at Harvard University’s John F. Kennedy School of Government and the convenor of the ARC Centre of Excellence in Policing and Security’s Knowledge Integration research program. She is developing the new discipline of Integration and Implementation Sciences to improve research strengths for tackling complex real-world problems through synthesis of disciplinary and stakeholder knowledge, comprehensively understanding and managing unknowns and providing integrated research support for policy and practice change. Her publications include the following books: Uncertainty and Risk: Multidisciplinary Perspectives (co-editor), Research Integration Using Dialogue Methods (co-author), Dealing with Uncertainties in Policing Serious Crime (editor) and Bridging the ‘Know-Do’ Gap: Knowledge Brokering to Improve Child Wellbeing (co-editor).
Mr. Shane Kawenata Bradbrook
Senior Public Health Advisor (Tobacco) at Regional Public Health
Shane Bradbrook was Director of Te Reo Marama (Maori advocacy voice) for 11.5 years. Currently he is working as the Senior Public Health Advisor on tobacco for Regional Public Health.
During his role in tobacco he has been engaged in a varied and diverse list of advocacy activities, events and milestones which include:
Key initiator of the Māori Affairs Select Committee Inquiry
Recipient of the international Nigel Gray Award 2009
Initiator of a culturally focused approach to Māori tobacco use – Kaupapa Tupeka Kore
Innovating for a change to Tobacco Resistance vs Tobacco Control
The development of the first National Māori Tobacco Control Strategy
Delegate on the development of the Framework Convention on Tobacco Control (FCTC) – inclusion of indigenous peoples clauses
Development of the Declaration of Tamaki-Makaurau on indigenous tobacco use
The development of Aukati Kai Paipa (Maori focused cessation programme)
Provided advice on various Government & NGO publications e.g. Clearing the Smoke and Vision 2020
Development of indigenous advocacy campaigns – ‘Maori Murder’, ‘Endangered Species I & II’, ‘Māori Killers’
NZAID advocacy workshops in the Pacific Islands – Tonga, Cook Is, Tuvalu, Samoa, Solomon Islands, Vanuatu
Development of international indigenous body United Indigenous Peoples on Tobacco Resistance
Removal of two cigarette brands – ‘Maori Mix’, ‘New Zealand’
Altria (Phillip Morris International) – received world first apology by a tobacco company to Māori for using ‘Maori Mix’ as a branded cigarette in Israel
Nominee for international Business Ethics Award (USA).
Dr. Maggie Brady
Annual James Rankin Orator
Dr Maggie Brady is an experienced social anthropologist and has undertaken research on Aboriginal health, alcohol and other drug use, and land tenure in the Northern Territory, South Australia and Western Australia. She also worked with Aboriginal people at Maralinga for the Royal Commission into British Nuclear Tests in Australia. Maggie did fieldwork in central and northern Australia for several studies in the 1980s, including one on alcohol use in Tennant Creek, and a major project on petrol sniffing which resulted in the book Heavy Metal (Aboriginal Studies Press 1992). Since then she has published for both academic and community-based audiences, including studies of natural recovery from alcohol abuse among Aboriginal and Torres Strait Islanders, (Giving Away the Grog 1995) and a book of community development strategies for managing alcohol problems (The Grog Book, 1998, 2005). She has also published on alcohol policy and Indigenous people (Indigenous Australia and Alcohol Policy, 2004), and recently the AERF published her set of six resource books on the history of Indigenous alcohol use (First Taste, 2007). Maggie’s interests include the role of primary health care in alcohol interventions for Indigenous people, and Indigenous involvement in the liquor industry through community-ownership of licensed premises. She is an ARC QEII fellow at the Centre for Aboriginal Economic Development at the Australian National University.
Prof. Ernest Drucker, PhD
Professor Emeritus of Family and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine
Ernest Drucker is Professor Emeritus of Family and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine; Adjunct Professor of Epidemiology at Columbia University’s Mailman School of Public Health; Senior Research Associate and Scholar in Residence at John Jay College of Criminal Justice of The City University of NY. He is licensed as a Clinical Psychologist in NY State; conducts research in AIDS, drug policy and prisons; and is active in public health and human rights efforts in the US and abroad. He founded Montefiore’s 1000 patient drug treatment program in 1970 and served as its Director until 1990; is an NIH funded principal investigator since 1991 and author of over 100 peer reviewed scientific articles, texts, and book chapters. Dr. Drucker is a founder and Honored Life Member of the International Harm Reduction Association; and a founder and Chairman of the Board of Doctors of the World / USA (1993-1997) . He was a founding editor of The International Journal of Drug Policy; founder and Editor in Chief ( with John Booth Davies) of Addiction Research and Theory ( 1993- 2005); and founding Editor in Chief of the Harm Reduction Journal. He is a Fellow of the Open Society Institute’s Soros Justice Fellowship and is a 2010- 2011 Senior Specialist in Global Health of the US/Australian Fulbright Program, and author of A Plague of Prisons: The Epidemiology of Mass Incarceration in America, published by The New Press, September of 2011.
Prof. Benedikt Fischer, PhD.
Benedikt Fischer, PhD, is Professor, CIHR/PHAC Research Chair in Applied Public Health, and Director, Centre for Applied Research in Mental Health (CARMHA), Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada; he is also a Senior Scientist, Centre for Addiction and Mental Health (CAMH), Toronto. Dr. Fischer’s research program encompasses psychoactive substance use, mental health and other co-morbidities; marginalized populations; public health and policy. In recent years, one of Dr. Fischer’s main research foci have been the epidemiology of, evidence-based interventions and policy development for non-medical prescription opioid use in Canada and internationally.
Prof. Iain McGregor
Professor of Psychopharmacology, University of Sydney
Iain McGregor is Professor of Psychopharmacology, ARC Professorial Fellow and Director of the Psychopharmacology Laboratory in the School of Psychology at the University of Sydney. Iain is one of Australia’s leading researchers in the fields of psychopharmacology and neuroscience. His research focuses on the effects of recreational drugs and prescription drug on brain and behaviour and also involves development of new medications for the treatment of anxiety, depression and addiction. This research involves both human clinical studies and research with laboratory animals. Iain also trains clinical psychologists and drug and alcohol workers in psychopharmacology and his forthcoming book “Meds for Heads” is a user-friendly introduction to prescription psychotropic drugs.
Prof. Rob Moodie
Professor of Global Health at the University of Melbourne’s Nossal Institute
Rob Moodie is Professor of Global Health at the University of Melbourne’s Nossal Institute. Between 1998 and 2007 he was the CEO of VicHealth.
Since 1979 he has worked for Save the Children Fund, Medicins Sans Frontieres, the Aboriginal Health Service in Alice Springs, the Burnet Institute, WHO and UNAIDS.
He was Chair of the National Preventative Health Task Force from 2008-2011, and recently coordinated the Declaration from the First Global Ministerial Meeting on NCDs held in Moscow in April.
He is co-author of four books, his latest being Recipes for a Great Life, written with Gabriel Gate.
Dr. Alessandro Pirona
MSc, PhD
Alessandro Pirona is a psychologist with a PhD in experimental psychology from Sussex University. As a researcher he investigated the abuse liability of recreational drugs in young people. In 2007, he joined the European Monitoring Centre for Drugs and Drug Addiction as a scientific analyst in the Intervention, Best Practice and Scientific Partners Unit. He is responsible for the monitoring of health and social responses in the EU, with a particular interest in drug treatment. He has been project manager of a number of key EMCDDA publications, such as Insights and Selected Issues on internet-based treatment, treatment and care for ageing drug users and the latest one on supervised heroin-assisted treatment in Europe and beyond.
Shane Bradbrook was Director of Te Reo Marama (Maori advocacy voice) for 11.5 years. Currently he is working as the Senior Public Health Advisor on tobacco for Regional Public Health.
Dr Maggie Brady is an experienced social anthropologist and has undertaken research on Aboriginal health, alcohol and other drug use, and land tenure in the Northern Territory, South Australia and Western Australia. She also worked with Aboriginal people at Maralinga for the Royal Commission into British Nuclear Tests in Australia. Maggie did fieldwork in central and northern Australia for several studies in the 1980s, including one on alcohol use in Tennant Creek, and a major project on petrol sniffing which resulted in the book Heavy Metal (Aboriginal Studies Press 1992). Since then she has published for both academic and community-based audiences, including studies of natural recovery from alcohol abuse among Aboriginal and Torres Strait Islanders, (Giving Away the Grog 1995) and a book of community development strategies for managing alcohol problems (The Grog Book, 1998, 2005). She has also published on alcohol policy and Indigenous people (Indigenous Australia and Alcohol Policy, 2004), and recently the AERF published her set of six resource books on the history of Indigenous alcohol use (First Taste, 2007). Maggie’s interests include the role of primary health care in alcohol interventions for Indigenous people, and Indigenous involvement in the liquor industry through community-ownership of licensed premises. She is an ARC QEII fellow at the Centre for Aboriginal Economic Development at the Australian National University.
Ernest Drucker is Professor Emeritus of Family and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine; Adjunct Professor of Epidemiology at Columbia University’s Mailman School of Public Health; Senior Research Associate and Scholar in Residence at John Jay College of Criminal Justice of The City University of NY. He is licensed as a Clinical Psychologist in NY State; conducts research in AIDS, drug policy and prisons; and is active in public health and human rights efforts in the US and abroad. He founded Montefiore’s 1000 patient drug treatment program in 1970 and served as its Director until 1990; is an NIH funded principal investigator since 1991 and author of over 100 peer reviewed scientific articles, texts, and book chapters. Dr. Drucker is a founder and Honored Life Member of the International Harm Reduction Association; and a founder and Chairman of the Board of Doctors of the World / USA (1993-1997) . He was a founding editor of The International Journal of Drug Policy; founder and Editor in Chief ( with John Booth Davies) of Addiction Research and Theory ( 1993- 2005); and founding Editor in Chief of the Harm Reduction Journal. He is a Fellow of the Open Society Institute’s Soros Justice Fellowship and is a 2010- 2011 Senior Specialist in Global Health of the US/Australian Fulbright Program, and author of A Plague of Prisons: The Epidemiology of Mass Incarceration in America, published by The New Press, September of 2011.
Benedikt Fischer, PhD, is Professor, CIHR/PHAC Research Chair in Applied Public Health, and Director, Centre for Applied Research in Mental Health (CARMHA), Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada; he is also a Senior Scientist, Centre for Addiction and Mental Health (CAMH), Toronto. Dr. Fischer’s research program encompasses psychoactive substance use, mental health and other co-morbidities; marginalized populations; public health and policy. In recent years, one of Dr. Fischer’s main research foci have been the epidemiology of, evidence-based interventions and policy development for non-medical prescription opioid use in Canada and internationally.
Iain McGregor is Professor of Psychopharmacology, ARC Professorial Fellow and Director of the Psychopharmacology Laboratory in the School of Psychology at the University of Sydney. Iain is one of Australia’s leading researchers in the fields of psychopharmacology and neuroscience. His research focuses on the effects of recreational drugs and prescription drug on brain and behaviour and also involves development of new medications for the treatment of anxiety, depression and addiction. This research involves both human clinical studies and research with laboratory animals. Iain also trains clinical psychologists and drug and alcohol workers in psychopharmacology and his forthcoming book “Meds for Heads” is a user-friendly introduction to prescription psychotropic drugs.
Rob Moodie is Professor of Global Health at the University of Melbourne’s Nossal Institute. Between 1998 and 2007 he was the CEO of VicHealth.
Alessandro Pirona is a psychologist with a PhD in experimental psychology from Sussex University. As a researcher he investigated the abuse liability of recreational drugs in young people. In 2007, he joined the European Monitoring Centre for Drugs and Drug Addiction as a scientific analyst in the Intervention, Best Practice and Scientific Partners Unit. He is responsible for the monitoring of health and social responses in the EU, with a particular interest in drug treatment. He has been project manager of a number of key EMCDDA publications, such as Insights and Selected Issues on internet-based treatment, treatment and care for ageing drug users and the latest one on supervised heroin-assisted treatment in Europe and beyond.
